MORRIS PLAINS, N.J., Dec. 2, 2013 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that five posters on its product candidates will be presented at the 55th American Society of Hematology Annual Meeting, scheduled for December 7 – 10, 2013 in New Orleans, LA. Details of the presentations are listed below (all times are in Eastern Time):
Help employers find you! Check out all the jobs and post your resume.
